Education
About Us
Working with TipRanks
Follow Us
Diagnos (TSE:ADK)
:ADK
ADK Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.43
Previous CloseN/A
Volume270.50K
Average Volume (3M)112.83K
Market Cap
C$20.37M
Enterprise ValueN/A
Total Cash (Recent Filing)C$2.82M
Total Debt (Recent Filing)C$3.29M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding101,862,976
10 Day Avg. Volume125,614
30 Day Avg. Volume112,831
Financial Highlights & Ratios
PEG Ratio1.93
Price to Book (P/B)-62.85
Price to Sales (P/S)0.00
P/FCF Ratio-10.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Diagnos News
PremiumCompany Announcements
Diagnos Strengthens US Market Position with New Advisory Board Member
PremiumCompany Announcements
Diagnos Inc. Strengthens US Market Strategy with New Advisory Board Member
PremiumCompany Announcements
DIAGNOS Engages Allele Capital for Strategic Advisory
PremiumCompany Announcements
Diagnos Inc. Extends Convertible Debentures Maturity Date
PremiumCompany Announcements
DIAGNOS Achieves Cybersecurity Milestone for CARA System
PremiumCompany Announcements
Diagnos Inc. Announces Amendment to Convertible Debentures
PremiumCompany Announcements
Diagnos’ CARA System License Application Advances with Health Canada
PremiumCompany Announcements
Diagnos Inc. Amends Convertible Debentures TermsOptions Prices
Currently, No data available
---
Ownership Overview
2.50% Insiders
―
Mutual Funds
0.29% Other Institutional Investors
97.21% Public Companies and
Individual Investors
ADK FAQ
What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.43 in the past 12 months.
What is Diagnos’s market cap?
Diagnos’s market cap is C$20.37M.
When is Diagnos’s upcoming earnings report date?
Diagnos’s upcoming earnings report date is Aug 21, 2025 which is in 70 days.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on May 28, 2025. The company reported -C$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.013.
Is Diagnos overvalued?
According to Wall Street analysts Diagnos’s price is currently Overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos have?
Diagnos has 101,862,976 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
Diagnos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$12.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.03%
12-Months-Change
Fundamentals
Return on Equity
366.78%
Trailing 12-Months
Asset Growth
447.78%
Trailing 12-Months
Company Description
Diagnos
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Technical Analysis
Aiml Resources
―
Treatment.com International
―
Telecure Technologies Inc
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―